blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3845222

EP3845222 - MICROENCAPSULATED FORMULATION COMPRISING DIOSMIN, TROXERUTIN AND COUMARINS, COMPOSITIONS THEREOF AND USE THEREOF FOR THE TREATMENT OF CIRCULATORY DISORDERS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.01.2024
Database last updated on 13.11.2024
FormerThe patent has been granted
Status updated on  10.02.2023
FormerGrant of patent is intended
Status updated on  11.10.2022
FormerRequest for examination was made
Status updated on  04.06.2021
Most recent event   Tooltip30.08.2024Lapse of the patent in a contracting state
New state(s): MC		published on 02.10.2024  [2024/40]
Applicant(s)For all designated states
Pharma Line S.r.l.
Via Bertani Agostino, 2
20154 Milano / IT
[2021/27]
Inventor(s)01 / Pezzini, Pietro
46100 Mantova (MN) / IT
 [2023/11]
Former [2021/27]01 / SIDOTI, Rossana
c/o PHARMA LINE S.R.L.
Via Bertani Agostino, 2
20154 Milano / IT
Representative(s)Hoffmann Eitle
Hoffmann Eitle S.R.L.
Piazza Sigmund Freud 1
20154 Milano / IT
[2021/27]
Application number, filing date20216167.521.12.2020
[2021/27]
Priority number, dateIT2019002490419.12.2019         Original published format: IT201900024904
[2021/27]
Filing languageIT
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3845222
Date:07.07.2021
Language:EN
[2021/27]
Type: B1 Patent specification 
No.:EP3845222
Date:15.03.2023
Language:EN
[2023/11]
Search report(s)(Supplementary) European search report - dispatched on:EP20.04.2021
ClassificationIPC:A61K9/20
[2021/27]
CPC:
A61K9/2068 (EP); A61K9/2009 (EP); A61K9/2013 (EP);
A61K9/2054 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/27]
TitleGerman:MIKROVERKAPSELTE FORMULIERUNG MIT DIOSMIN, TROXERUTIN UND CUMARINEN, ZUSAMMENSETZUNGEN DAVON UND VERWENDUNG DAVON ZUR BEHANDLUNG VON KREISLAUFERKRANKUNGEN[2021/27]
English:MICROENCAPSULATED FORMULATION COMPRISING DIOSMIN, TROXERUTIN AND COUMARINS, COMPOSITIONS THEREOF AND USE THEREOF FOR THE TREATMENT OF CIRCULATORY DISORDERS[2021/27]
French:FORMULATION MICROENCAPSULÉE COMPRENANT DE LA DIOSMINE, DE LA TROXÉRUTINE ET DES COUMARINES, LEURS COMPOSITIONS ET LEUR UTILISATION POUR LE TRAITEMENT DES TROUBLES CIRCULATOIRES[2021/27]
Examination procedure21.12.2020Examination requested  [2021/27]
05.01.2022Amendment by applicant (claims and/or description)
12.10.2022Communication of intention to grant the patent
02.02.2023Fee for grant paid
02.02.2023Fee for publishing/printing paid
02.02.2023Receipt of the translation of the claim(s)
Opposition(s)18.12.2023No opposition filed within time limit [2024/08]
Fees paidRenewal fee
14.12.2022Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.03.2023
CZ15.03.2023
DK15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
MC15.03.2023
NL15.03.2023
PL15.03.2023
RO15.03.2023
RS15.03.2023
SE15.03.2023
SI15.03.2023
SK15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
IS15.07.2023
PT17.07.2023
[2024/40]
Former [2024/10]AT15.03.2023
CZ15.03.2023
DK15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
PL15.03.2023
RO15.03.2023
RS15.03.2023
SE15.03.2023
SI15.03.2023
SK15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
IS15.07.2023
PT17.07.2023
Former [2023/50]AT15.03.2023
CZ15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
PL15.03.2023
RO15.03.2023
RS15.03.2023
SE15.03.2023
SK15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
IS15.07.2023
PT17.07.2023
Former [2023/49]AT15.03.2023
CZ15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
RO15.03.2023
RS15.03.2023
SE15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
PT17.07.2023
Former [2023/48]AT15.03.2023
EE15.03.2023
ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
RS15.03.2023
SE15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
PT17.07.2023
Former [2023/46]ES15.03.2023
FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
RS15.03.2023
SE15.03.2023
SM15.03.2023
NO15.06.2023
GR16.06.2023
PT17.07.2023
Former [2023/38]FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
NL15.03.2023
RS15.03.2023
SE15.03.2023
NO15.06.2023
GR16.06.2023
Former [2023/37]FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
RS15.03.2023
SE15.03.2023
NO15.06.2023
GR16.06.2023
Former [2023/36]FI15.03.2023
HR15.03.2023
LT15.03.2023
LV15.03.2023
RS15.03.2023
SE15.03.2023
NO15.06.2023
Former [2023/35]HR15.03.2023
LT15.03.2023
RS15.03.2023
NO15.06.2023
Former [2023/34]LT15.03.2023
RS15.03.2023
Former [2023/33]LT15.03.2023
Documents cited:Search[XI]  - Pharma Line S.R.L., "Venolen Plus", (20191018), URL: https://www.pharma-line.it/sites/default/files/2020-06/Venolen%20plus_IT_FI01%2018-10-19.pdf, (20200910), XP055729733 [X] 1-11 * the whole document * [I] 12
Examination   - First communication to the Italian Ministry of the notification of releasing the product "Venolen plus compresse rivestite" on the italian market.
    - Technical data sheet of the commercial product "Venolen plus"
by applicant   - CAS, no. 56764-99-9
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.